FDA Clears Access Vascular HydroMid® and HydroPICC® Catheters With Anti-Thrombogenic Indication

Access Vascular, Inc. (AVI), a leader in advanced vascular access solutions, today announced that the U.S. Food and Drug ...
Endovascular Today

Antithrombogenic Indication Cleared for Access Vascular’s HydroMid and HydroPICC

Access Vascular, Inc. announced that the FDA cleared a new indication for its single-lumen Mimix HydroMid midline catheter and ...
Medscape

Risk Factors and Prognosis for Clot Formation on Cardiac Device Leads

Only 15 of 1,086 (1.4%) cardiac device patients who underwent TTE were found to have thrombus adhered to a device lead without the diagnosis of endocarditis. These 15 patients comprised our study ...
The American Journal of Managed Care

Clot Formation, Fibrinolysis Assays May Help Show Important Differences Between Hemophilia A Treatments

“Compared to normal plasma, hemophilia plasma delays clot formation and reduces stability in tissue factor-triggered assays, and products that enhance hemostasis improve these characteristics.” All ...
Healthline

What Are Direct Oral Anticoagulants (DOACs)?

DOACs are a newer class of anticoagulants that are more targeted and work faster than traditional options. They also don’t require frequent monitoring and have fewer dietary restrictions. Direct oral ...